Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy

Kidney International

Volumn 54, Issue 1, 1998, Pages 193-202

  Weiss, Miriam F ^u   Rodby, Roger A ^v   Justice, Amy C ^v   Hricik, Donald E ^v   Lewis, Edmund J ^a   Rohde, Richard ^a   Bain, Raymond P ^b   Evans, J K ^b   Turlington, T R ^b   Burrows, P K ^b   Sheehan, J ^c   Pohl, M ^d   Berl, T ^e   Lemann Jr , J ^f   Blumenthal, S ^f   Bresnahan, S ^f   Hebert, L ^g   Nahman Jr , N S ^g   Rodby, R ^a   McGill, J ^h   Whittier, F ⁱ   Cattran, D ^j   Hano, J ^k   Hunsicker, L ^l   Maxwell, D ^m   Porush, J ⁿ   Spitalewitz, S ⁿ   Shapiro, K ^o   Adler, S ^p   Tolchin, N ^q   Svetkey, L ^r   Sharon, Z ^s   Rausenbaum, B ^s   Breyer, J ^t   Shulman, G ^t   more..

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g OHIO STATE UNIVERSITY   (United States)

^h WASHINGTON UNIVERSITY   (United States)

ⁱ NE Ohio Universities Coll of Med   (United States)

^j UNIVERSITY OF TORONTO   (Canada)

^k LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^l UNIVERSITY OF IOWA   (United States)

^m INDIANA UNIVERSITY   (United States)

ⁿ BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

^o Nyack Hospital   (United States)

^p HARBOR UCLA MEDICAL CENTER   (United States)

^q Nephrology Int Med Specialists P   (United States)

^r DUKE UNIVERSITY   (United States)

^s Atlanta Nephrology Referral Center   (United States)

^t VANDERBILT UNIVERSITY   (United States)

^u UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^v University Hospitals of Cleveland ^*

more..

Author keywords

Advanced glycation end products; Diabetic complications; Diabetic nephropathy; Neopterin; Pentosidine

Indexed keywords

C REACTIVE PROTEIN; GLYCOSYLATED HEMOGLOBIN; GLYCOSYLATED PROTEIN; INTERLEUKIN 6; NEOPTERIN;

ADULT; ARTICLE; BLOOD LEVEL; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; URINALYSIS;

EID: 7144264416     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00982.x     Document Type: Article

References (40)

1. HELD P, PORT F, WEBB R, WOLFE, BLOEMBERGEN W, TURENNE M, HIRTH R, YOUNG E, OJO A, STRAWDERMAN R, WOODS J, THDESCHI P, CARROLL C, HULBERT-SHEARON T, ZHANG Q, LEVINE G, HATCHER D, JONES C, GREER J, AGODOA L: Excerpts from United States Renal Data System 1996 Annual Data Report. Am J Kidney Dis 28(Suppl 2):S1-S165, 1996
2. HARRIS M, HADDEN W, KNOWLES W: Prevalence of diabetes and impaired glucose tolerance and plasma levels in US population aged 20-74. Diabetes 36:523-534, 1989
3. HARRIS M: Diabetes in America, in National Diabetes Data Group, Bethesda, National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases, 1995
4. PARVING H, HOMMEL E, MATHIESEN E, SKOTT P, EDSBERG B, BAHNSEN M, LAURITZEN M, HOUGAARD P, LAURITZEN E: Prevalence of microalbuminuria. arterial hypertension, retinopathy and neuropathy in patients with insulin-dependent diabetes. Br Med J 296:156-160, 1988
5. LEWIS E, HUNSICKER L, BAIN R, ROHDE R: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
6. RAVID M, SAVIN H, JUTRIN I, BENTAL T, KATZ B, LISHNER M: Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 118:577-581, 1993
7. PARVING H, ROSSIG P, HOMMEL E, SMIDT U, ANGIOTENSIN-CONVERTING enzyme inhibition in diabetic nephropathy: Ten years experience, in Renal Disease Progression and Management, edited by AURAN M, KLAHR S, Philadelphia, W.B. Saunders, 1996, pp 58-66
8. THE DIABETES CONTROL, COMPLICATIONS TRIAL RESEARCH GROUP: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
9. NJOROGE F, MONNIER V: The chemistry of the Maillard reaction under physiological conditions: A review. Prog Clin Biol Res 304:85-107, 1989
10. BUCALA R, CERAMI A: Advanced glycosylation: Chemistry, biology, and implications for diabetes and aging. Adv Pharmacol 23:1-34, 1992
11. BROWNLEE M, CERAMI A, VLASSARA H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321, 1988
12. BROWNLEE M: Glycation and diabetic complications. Diabetes 43:836-841, 1994
13. SELL D, MONNIER V: Structure elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem 264:21597-21602, 1989
14. SELL D, LAPOLLA A, ODETTI P, FOGARTY J, MONNIER V: Pentosidine formation in skin correlates with severity of complications in individuals with long standing IDDM. Diabetes 41:1286-1242, 1992
15. BEISSWENGER P, MOORE L, BRINK-JOHNSON T: Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J Clin Invest 92:212-217, 1993
16. SELL DR, MONNIER VM: End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J Clin Invest 85:380-384, 1990
17. MIYATA T, UEDA Y, SHINZATO T, IIDA Y, TANAKA S, KURAKAWA K, VAN YPERSELE DE STRIHOU C, MAEDA K: Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end stage renal failure: Renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 7:1198-1206, 1996
18. FRIEDLANDER M, WU Y, ELGAWISH A, MONNIER V: Early and advanced glycosylation end products: Kinetics of formation and clearance in peritoneal dialysis. J Clin Invest 97:728-735, 1996
19. TAKAHASHI M, OHISHI T, AOSHIMA H, KAWANA K, KUSHIDA K, INOUE T, HORIUCHI K: The Maillard protein cross-link pentosidine in urine from diabetic patients. Diabetologica 36:664-667, 1993
20. TAKAHASHI M, KUSHIDA K, KAWANA K, ISHIHARA C, DENDA M, INOUF T, HORIUCHI K: Quantification of the cross-link pentosidine in serum from normal and uremic subjects. Clin Chem 39:2162-2165, 1993
21. FRIEDLANDER M, WITKO-SARSAT V, NGUYEN A, WU Y, LABRUNIE M, VERGER C, JUNGERS P, DESCAMPS-LATSCHA B: The advanced glycation endproduct pentosidine and monocyte activation in uremia. Clin Nephrol 45:379-382, 1996
22. BREYER J, BAIN R, EVANS J, NAHMAN N, LEWIS E, COOPER M, MCGILL J, BERL T, THE COLLABORATIVE STUDY GROUP: Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. Kidney Int 50:1651-1658, 1996
23. GUGLIUCCI A, BENDAYAN M: Renal fate of circulating advanced glycated end products (AGE): Evidence for reabsorption and cutabolism of AGE-peptides by renal proximal tubular cells. Diabetologia 39:149-160, 1996
24. SATO K, INAZU A, YAMAGUCHI S, NAKAYAMA T, DEYASHIKI Y, SAWADA H, HARA A: Monkey 3-deoxyglucosone reductase: Tissue distribution and purification of three multiple forms of the kidney enzyme that are identical with dihydrodiol dehydrogenase, aldehyde reductase and aldose reductase. Arch Biochem Biophys 307:286-294, 1993
25. MAKITA Z, BUCALA R, RAYFIELD EJ, FRIEDMAN EA, KAUFMAN AM, KORBET SM, BARTH RH, WINSTON JA, FUH H, MANOGUE KR, CERAMI A, VLASSARA H: Reactive glycosylation endproducts in diabetic uremia and treatment of renal failure. Lancet 343:1519-1522, 1994
26. MIYATA T, UEDA Y, HORIE K, NANGAKU M, TANAKA S, STRIHOU CVD, KUROKAWA K: Renal catabolism of advanced glycation end products: The fate of pentosidine. Kidney Int 53:416-422, 1998
27. NEEPER M, SCHMIDT A, BRETT J, YAN S, WANG F, PAN Y, ELLISTON K, STERN D, SHAW A: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267:14998-15004, 1992
28. SCHMIDT A, VIANNA M, GERLACH M, BRETT J, RYAN J, KAO J, ESPOSITO C, HEGARTY H, HURLEY W, CLAUSS M, WANG F, PAN Y, TSANG T, STERN D: Isolation and characterization of binding proteins for advanced glycation end products from lung tissue which are present on the endothelial cell surface. J Biol Chem 267:14987-14997, 1992
29. BRETT J, SCHMIDT A, YAN S, Zou Y, WEIDMAN E, PINSKY D, NOWYGROD R, NEEPER M, PRZYSIECKI C, SHAW A, MIGHELI A, STERN D: Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 143:1699-1712, 1993
30. RITTHALER U, DENG Y, ZHANG Y, GRETEN J, ABEL M, SIDO B, ALLENBERG J, OTTO G, ROTH H, BIERHAUS A, ZIEGLER R, SCHMIDT A, WALDHERR R, WAHL P, STERN D, NAWROTH P: Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. Am J Pathol 146:688-694, 1995
31. VLASSARA H, FUH H, MAKITA Z, KRUNGKRAI S, CERAMI A, BUCALA R: Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: A model for diabetic and aging complications. Proc Natl Acad Sci USA 89:12043-12047, 1992
32. YAN S, SCHMIDT A, ANDERSON G, ZHANG; J, BRETT J, ZOU Y, PINSKY D, STERN D: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269:9889-9897, 1994
33. MIYATA T, WADA Y, CAL Z, IIDA Y, HORIE K, YASUDA Y, MAEDA K, KURAKOWA K, VAN YPERSELE DE STRIHOU C: Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end stage renal failure. Kidney Int 51:1170-1181, 1997
34. DESCAMPS-LATSCHA B, HERBELIN A, NGUYEN AT, ZINGRAFF J, JUNGERS P, CHATENOUD L: Immune system dysregulation in uremia. Semin Nephrol 14:253-260, 1994
35. HERBELIN A, URENA P, NGUYEN A, ZINGRAFF J, DESCAMPS-LATSCHA B: Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int 39:954-960, 1991
36. NIJSTEN M, DEGROOT E, DUIS JT, KLASEN H, HACK C, AARDERN L: Serum levels of IL-6 and acute phase responses. Lancet 2:921-925, 1987
37. KAIZU Y, KIMURA M, YONEYAMA T, MIYAJI K, HIBI I, KUMAGAI H: Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis 31:93-100, 1998
38. 1-acid glycoprotein and fibrinogen. Semin Arthritis Rheum 20:129-147, 1990
39. WERNER E, WERNER-FELMAYER G, FUCHS D, HAUSEN A, REIBNFGGER R, YIM J, WACHTER H: Biochemistry and function of pteridine synthesis in human and murine macrophages. Pathobiology 59:276-279, 1991
40. FUCHS D, HAUSEN A, REIBNEGGER G, WERNER E, DIERICH M, WACHTER H: Neopterin as a marker for activated cell mediated immunity: Application in HIV infection. Immunol Today 9:150-155, 1988